Literature DB >> 24583613

Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay.

Andrew F Longosz1, Charles S Morrison, Pai-Lien Chen, Eric Arts, Immaculate Nankya, Robert A Salata, Veronica Franco, Thomas C Quinn, Susan H Eshleman, Oliver Laeyendecker.   

Abstract

INTRODUCTION: Analysis of samples from Uganda using serologic HIV incidence assays reveal that individuals with subtype D infection often have weak humoral immune responses to HIV infection. It is unclear whether this reflects a poor initial response to infection or a waning antibody response later in infection.
MATERIALS AND METHODS: Samples (N = 2614) were obtained from 114 women aged 18-45 years in the Ugandan Genital Shedding and Disease Progression Study cohort (2001-2009; 82 subtype A, 32 subtype D; median 23 samples/women, range 3-41 samples, median follow-up of 6.6 years). Samples were analyzed using the BED capture immunoassay (cutoff, 0.8 OD-n) and the avidity assay (cutoff, 90% Avidity Index). Antibody maturation was assessed by having the BED capture enzyme immunoassay (BED-CEIA) or avidity value exceed the assay cutoff 1 or 2 years after infection. The waning antibody response was measured by having the BED-CEIA or avidity value fall >20% below the maximum value.
RESULTS: For the BED-CEIA, 8 women with subtype A infection and 3 women with subtype D infection never progressed previously the cutoff value (median, 5.9 years follow-up after infection). Six women with subtype D infection never achieved an avidity index >90%. Subtype did not impact the proportion of women whose assay values regressed by >20% of the maximal value (for BED-CEIA: 33% for A, 41% for D, P = 0.51; for avidity: 1% for A, 6% for D, P = 0.19). DISCUSSION: The higher frequency of misclassification of individuals with long-term subtype D infection as recently infected using serologic incidence assays reflects a weak initial antibody response to HIV infection that is sustained over time.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24583613      PMCID: PMC3942792          DOI: 10.1097/QAI.0000000000000006

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  27 in total

1.  Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion.

Authors:  Trudy Dobbs; Susan Kennedy; Chou-Pong Pau; J Steven McDougal; Bharat S Parekh
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

Review 2.  Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation.

Authors:  Michael P Busch; Christopher D Pilcher; Timothy D Mastro; John Kaldor; Gaby Vercauteren; William Rodriguez; Christine Rousseau; Thomas M Rehle; Alex Welte; Megan D Averill; Jesus M Garcia Calleja
Journal:  AIDS       Date:  2010-11-27       Impact factor: 4.177

3.  Loss to follow-up effect in investigations of HIV-1 incidence.

Authors:  C Beyrer; K E Nelson
Journal:  Lancet       Date:  1997-03-01       Impact factor: 79.321

4.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

5.  Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence.

Authors:  Bharat S Parekh; M Susan Kennedy; Trudy Dobbs; Chou-Pong Pau; Robert Byers; Timothy Green; Dale J Hu; Suphak Vanichseni; Nancy L Young; Kachit Choopanya; Timothy D Mastro; J Steven McDougal
Journal:  AIDS Res Hum Retroviruses       Date:  2002-03-01       Impact factor: 2.205

Review 6.  HIV incidence estimation using the BED capture enzyme immunoassay: systematic review and sensitivity analysis.

Authors:  Till Bärnighausen; Thomas A McWalter; Zachary Rosner; Marie-Louise Newell; Alex Welte
Journal:  Epidemiology       Date:  2010-09       Impact factor: 4.822

7.  Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes.

Authors:  Bharat S Parekh; Debra L Hanson; John Hargrove; Bernard Branson; Timothy Green; Trudy Dobbs; Niel Constantine; Julie Overbaugh; J Steven McDougal
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-18       Impact factor: 2.205

8.  Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests.

Authors:  R Brookmeyer; T C Quinn
Journal:  Am J Epidemiol       Date:  1995-01-15       Impact factor: 4.897

9.  Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1.

Authors:  H I Thomas; S Wilson; C M O'Toole; C M Lister; A M Saeed; R P Watkins; P Morgan-Capner
Journal:  Clin Exp Immunol       Date:  1996-02       Impact factor: 4.330

10.  Global trends in molecular epidemiology of HIV-1 during 2000-2007.

Authors:  Joris Hemelaar; Eleanor Gouws; Peter D Ghys; Saladin Osmanov
Journal:  AIDS       Date:  2011-03-13       Impact factor: 4.177

View more
  9 in total

1.  Determination of HIV Status in African Adults With Discordant HIV Rapid Tests.

Authors:  Jessica M Fogel; Estelle Piwowar-Manning; Kelsey Donohue; Vanessa Cummings; Mark A Marzinke; William Clarke; Autumn Breaud; Agnès Fiamma; Deborah Donnell; Michal Kulich; Jessie K K Mbwambo; Linda Richter; Glenda Gray; Michael Sweat; Thomas J Coates; Susan H Eshleman
Journal:  J Acquir Immune Defic Syndr       Date:  2015-08-01       Impact factor: 3.731

2.  Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.

Authors:  Andrew F Longosz; David Serwadda; Fred Nalugoda; Godfrey Kigozi; Veronica Franco; Ronald H Gray; Thomas C Quinn; Susan H Eshleman; Oliver Laeyendecker
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-25       Impact factor: 2.205

3.  Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D.

Authors:  Andrew F Longosz; Charles S Morrison; Pai-Lien Chen; Hilmarie H Brand; Eric Arts; Immaculate Nankya; Robert A Salata; Thomas C Quinn; Susan H Eshleman; Oliver Laeyendecker
Journal:  AIDS Res Hum Retroviruses       Date:  2014-11-19       Impact factor: 2.205

4.  Computational analysis of antibody dynamics identifies recent HIV-1 infection.

Authors:  Kelly E Seaton; Nathan A Vandergrift; Aaron W Deal; Wes Rountree; John Bainbridge; Eduard Grebe; David A Anderson; Sheetal Sawant; Xiaoying Shen; Nicole L Yates; Thomas N Denny; Hua-Xin Liao; Barton F Haynes; Merlin L Robb; Neil Parkin; Breno R Santos; Nigel Garrett; Matthew A Price; Denise Naniche; Ann C Duerr; Sheila Keating; Dylan Hampton; Shelley Facente; Kara Marson; Alex Welte; Christopher D Pilcher; Myron S Cohen; Georgia D Tomaras
Journal:  JCI Insight       Date:  2017-12-21

5.  Comparison of Self-report to Biomarkers of Recent HIV Infection: Findings from the START Trial.

Authors:  Katherine E Schlusser; Shweta Sharma; Pola de la Torre; Giuseppe Tambussi; Rika Draenert; Angie N Pinto; Julia A Metcalf; Danielle German; James D Neaton; Oliver Laeyendecker
Journal:  AIDS Behav       Date:  2018-07

6.  A national study of the molecular epidemiology of HIV-1 in Australia 2005-2012.

Authors:  Alison Castley; Shailendra Sawleshwarkar; Rick Varma; Belinda Herring; Kiran Thapa; Dominic Dwyer; Doris Chibo; Nam Nguyen; Karen Hawke; Rodney Ratcliff; Roger Garsia; Anthony Kelleher; David Nolan
Journal:  PLoS One       Date:  2017-05-10       Impact factor: 3.240

7.  Western Blot-Based Logistic Regression Model for the Identification of Recent HIV-1 Infection: A Promising HIV-1 Surveillance Approach for Resource-Limited Regions.

Authors:  Jiegang Huang; Minlian Wang; Chunyuan Huang; Bingyu Liang; Junjun Jiang; Chuanyi Ning; Ning Zang; Hui Chen; Jie Liu; Rongfeng Chen; Yanyan Liao; Li Ye; Hao Liang
Journal:  Biomed Res Int       Date:  2018-01-14       Impact factor: 3.411

8.  Comprehensive Profiling of HIV Antibody Evolution.

Authors:  Susan H Eshleman; Oliver Laeyendecker; Kai Kammers; Athena Chen; Mariya V Sivay; Sanjay Kottapalli; Brandon M Sie; Tiezheng Yuan; Daniel R Monaco; Divya Mohan; Daniel Wansley; Tomasz Kula; Charles Morrison; Stephen J Elledge; Ron Brookmeyer; Ingo Ruczinski; H Benjamin Larman
Journal:  Cell Rep       Date:  2019-04-30       Impact factor: 9.423

Review 9.  Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review.

Authors:  Shelley N Facente; Eduard Grebe; Andrew D Maher; Douglas Fox; Susan Scheer; Mary Mahy; Shona Dalal; David Lowrance; Kimberly Marsh
Journal:  JMIR Public Health Surveill       Date:  2022-03-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.